article thumbnail

Amgen And AbbVie In Legal Settlement

socalTECH

According to the two, AbbVie will grant a patent license for use and sale of the compound worldwide, on a country-by-country basis. As a result of the settlement, Amgen said it expects to launch its product in Europe in October of 2018, and its product for the United States in 2023.

article thumbnail

9 Strategies For Implementing An Innovative Business

Startup Professionals Musings

Developing the ideal product the first time around is unlikely, high risk, and very expensive in today’s chaotic market. Tesla has found that sharing many of their battery patents has expanded the market for all electric vehicle providers, as well as attracted the very best engineers to join Tesla’s team.